- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- Momentis Surgical receives FDA clearance for Anovo robotic platform to support multiport surgery
Momentis Surgical has received FDA 510(k) clearance for the multiport configuration of its Anovo® Surgical System, making it the first robotic platform designed to support natural orifice, single-port, and multiport surgical approaches on a single system. The expanded clearance increases the flexibi
- Wellumio raises $9.75M to advance portable AI-powered MRI system for stroke diagnosis
Wellumio has raised $9.75 million in an oversubscribed pre-Series A financing round to accelerate development of its portable, AI-powered MRI system for rapid stroke diagnosis at the point of care. The funding, backed by new investors Bioshore Ventures and Jumpspace Ventures alongside existing inves
- GS MedTech Funding Tracker – TYBR Health, Hilo, and more
AI became a major theme this week, alongside advances in regenerative medicine and connected care, as MedTech companies raised capital to accelerate commercialization and expand clinical impact. TYBR Health raises $30M Series A to expand orthopedic hydrogel platform TYBR Health has raised $30M in a
- TYBR Health raises $30M Series A to expand orthopedic hydrogel platform
TYBR Health has raised $30 million in a Series A financing round led by Vensana Capital and Mutual Capital Partners to expand commercialization of its B3 GEL hydrogel platform for orthopedic surgery. The funding will support broader market access, new clinical studies, and expanded indications for B
- CARPL.ai raises $10M Series A to accelerate global adoption of healthcare AI
CARPL.ai has raised $10 million in a Series A funding round led by the International Finance Corporation (IFC), with participation from Stellaris Venture Partners and other investors, to expand its radiology AI marketplace and enterprise platform. The company’s vendor-neutral platform gives healthca
- Spryte Medical completes enrollment in FDA IDE trial for neuro-OCT imaging system
Spryte Medical has completed enrollment in the INSYTE Trial, a key clinical study evaluating its investigational nOCT™ Imaging System for use during endovascular treatment of intracranial aneurysms. The FDA-approved IDE study enrolled 65 patients across 8 centers in 3 countries and is designed to as
- Traferox Technologies receives FDA approval for TorEx lung perfusion system
Traferox Technologies has received FDA Premarket Approval (PMA) for its TorEx® Lung Perfusion System, an ex vivo lung perfusion (EVLP) platform designed to assess donor lungs outside the body before transplantation. The system enables transplant teams to evaluate the function of donor lungs initiall
- Cardinal Health expands home care platform with $360M acquisition of Strive Medical and AdaptHealth
Cardinal Health has acquired urology-focused medical supplier Strive Medical and AdaptHealth’s diabetes business in a combined $360 million deal aimed at strengthening its at-home care solutions platform. The acquisitions expand Cardinal’s capabilities across diabetes management and urology, buildin
- Endo Tools Therapeutics raises $23M Series C to expand endomina platform
Endo Tools Therapeutics (ETT) has raised €20 million ($23 million) in an oversubscribed Series C financing round to accelerate commercialization of its endomina® platform and recently FDA-cleared endomina® EZFuse system. The round was led by Capricorn Partners through its Capricorn Healthtech Fund I
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
Momentis Surgical has received FDA 510(k) clearance for the multiport configuration of its Anovo® Surgical System, making it the first robotic platform designed to support natural orifice, single-port, and multiport surgical approaches on a single system.
The expanded clearance increases the flexibil
Wellumio has raised $9.75 million in an oversubscribed pre-Series A financing round to accelerate development of its portable, AI-powered MRI system for rapid stroke diagnosis at the point of care.
The funding, backed by new investors Bioshore Ventures and Jumpspace Ventures alongside existing invest
AI became a major theme this week, alongside advances in regenerative medicine and connected care, as MedTech companies raised capital to accelerate commercialization and expand clinical impact.
TYBR Health raises $30M Series A to expand orthopedic hydrogel platform
TYBR Health has raised $30M in a Se
TYBR Health has raised $30 million in a Series A financing round led by Vensana Capital and Mutual Capital Partners to expand commercialization of its B3 GEL hydrogel platform for orthopedic surgery.
The funding will support broader market access, new clinical studies, and expanded indications for B3
CARPL.ai has raised $10 million in a Series A funding round led by the International Finance Corporation (IFC), with participation from Stellaris Venture Partners and other investors, to expand its radiology AI marketplace and enterprise platform.
The company’s vendor-neutral platform gives healthcar
Spryte Medical has completed enrollment in the INSYTE Trial, a key clinical study evaluating its investigational nOCT™ Imaging System for use during endovascular treatment of intracranial aneurysms.
The FDA-approved IDE study enrolled 65 patients across 8 centers in 3 countries and is designed to ass
Traferox Technologies has received FDA Premarket Approval (PMA) for its TorEx® Lung Perfusion System, an ex vivo lung perfusion (EVLP) platform designed to assess donor lungs outside the body before transplantation.
The system enables transplant teams to evaluate the function of donor lungs initially
Cardinal Health has acquired urology-focused medical supplier Strive Medical and AdaptHealth’s diabetes business in a combined $360 million deal aimed at strengthening its at-home care solutions platform.
The acquisitions expand Cardinal’s capabilities across diabetes management and urology, building
Endo Tools Therapeutics (ETT) has raised €20 million ($23 million) in an oversubscribed Series C financing round to accelerate commercialization of its endomina® platform and recently FDA-cleared endomina® EZFuse system.
The round was led by Capricorn Partners through its Capricorn Healthtech Fund II